1
|
Stipniece L, Ramata-Stunda A, Vecstaudza J, Kreicberga I, Livkisa D, Rubina A, Sceglovs A, Salma-Ancane K. A Comparative Study on Physicochemical Properties and In Vitro Biocompatibility of Sr-Substituted and Sr Ranelate-Loaded Hydroxyapatite Nanoparticles. ACS APPLIED BIO MATERIALS 2023; 6:5264-5281. [PMID: 38039078 PMCID: PMC10731655 DOI: 10.1021/acsabm.3c00539] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2023] [Revised: 11/06/2023] [Accepted: 11/07/2023] [Indexed: 12/03/2023]
Abstract
Synthetic hydroxyapatite nanoparticles (nHAp) possess compositional and structural similarities to those of bone minerals and play a key role in bone regenerative medicine. Functionalization of calcium phosphate biomaterials with Sr, i.e., bone extracellular matrix trace element, has been proven to be an effective biomaterial-based strategy for promoting osteogenesis in vitro and in vivo. Functionalizing nHAp with Sr2+ ions or strontium ranelate (SrRAN) can provide favorable bone tissue regeneration by locally delivering bioactive molecules to the bone defect microenvironment. Moreover, administering an antiosteoporotic drug, SrRAN, directly into site-specific bone defects could significantly reduce the necessary drug dosage and the risk of possible side effects. Our study evaluated the impact of the Sr source (Sr2+ ions and SrRAN) used to functionalize nHAp by wet precipitation on its in vitro cellular activities. The systematic comparison of physicochemical properties, in vitro Sr2+ and Ca2+ ion release, and their effect on in vitro cellular activities of the developed Sr-functionalized nHAp was performed. The ion release tests in TRIS-HCl demonstrated a 21-day slow and continuous release of the Sr2+ and Ca2+ ions from both Sr-substituted nHAp and SrRAN-loaded HAp. Also, SrRAN and Sr2+ ion release kinetics were evaluated in DMEM to understand their correlation with in vitro cellular effects in the same time frame. Relatively low concentration (up to 2 wt %) of Sr in the nHAp led to an increase in the alkaline phosphatase activity in preosteoblasts and expression of collagen I and osteocalcin in osteoblasts, demonstrating their ability to boost bone formation.
Collapse
Affiliation(s)
- Liga Stipniece
- Rudolfs
Cimdins Riga Biomaterials Innovations and Development Centre of RTU,
Institute of General Chemical Engineering, Faculty of Materials Science
and Applied Chemistry, Riga Technical University, Pulka St. 3/3, Riga LV-1007, Latvia
- Baltic
Biomaterials Centre of Excellence, Headquarters
at Riga Technical University, Riga LV-1007, Latvia
| | - Anna Ramata-Stunda
- Department
of Microbiology and Biotechnology, Faculty of Biology, University of Latvia, Jelgavas St. 1, Riga LV-1004, Latvia
| | - Jana Vecstaudza
- Rudolfs
Cimdins Riga Biomaterials Innovations and Development Centre of RTU,
Institute of General Chemical Engineering, Faculty of Materials Science
and Applied Chemistry, Riga Technical University, Pulka St. 3/3, Riga LV-1007, Latvia
- Baltic
Biomaterials Centre of Excellence, Headquarters
at Riga Technical University, Riga LV-1007, Latvia
| | - Inta Kreicberga
- Rudolfs
Cimdins Riga Biomaterials Innovations and Development Centre of RTU,
Institute of General Chemical Engineering, Faculty of Materials Science
and Applied Chemistry, Riga Technical University, Pulka St. 3/3, Riga LV-1007, Latvia
- Baltic
Biomaterials Centre of Excellence, Headquarters
at Riga Technical University, Riga LV-1007, Latvia
| | - Dora Livkisa
- Department
of Microbiology and Biotechnology, Faculty of Biology, University of Latvia, Jelgavas St. 1, Riga LV-1004, Latvia
| | - Anna Rubina
- Rudolfs
Cimdins Riga Biomaterials Innovations and Development Centre of RTU,
Institute of General Chemical Engineering, Faculty of Materials Science
and Applied Chemistry, Riga Technical University, Pulka St. 3/3, Riga LV-1007, Latvia
- Baltic
Biomaterials Centre of Excellence, Headquarters
at Riga Technical University, Riga LV-1007, Latvia
| | - Artemijs Sceglovs
- Rudolfs
Cimdins Riga Biomaterials Innovations and Development Centre of RTU,
Institute of General Chemical Engineering, Faculty of Materials Science
and Applied Chemistry, Riga Technical University, Pulka St. 3/3, Riga LV-1007, Latvia
- Baltic
Biomaterials Centre of Excellence, Headquarters
at Riga Technical University, Riga LV-1007, Latvia
| | - Kristine Salma-Ancane
- Rudolfs
Cimdins Riga Biomaterials Innovations and Development Centre of RTU,
Institute of General Chemical Engineering, Faculty of Materials Science
and Applied Chemistry, Riga Technical University, Pulka St. 3/3, Riga LV-1007, Latvia
- Baltic
Biomaterials Centre of Excellence, Headquarters
at Riga Technical University, Riga LV-1007, Latvia
| |
Collapse
|
2
|
Xing X, Han Y, Cheng H. Biomedical applications of chitosan/silk fibroin composites: A review. Int J Biol Macromol 2023; 240:124407. [PMID: 37060984 DOI: 10.1016/j.ijbiomac.2023.124407] [Citation(s) in RCA: 14] [Impact Index Per Article: 14.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2023] [Revised: 03/31/2023] [Accepted: 04/06/2023] [Indexed: 04/17/2023]
Abstract
Natural polymers have been used in the biomedical fields for decades, mainly derived from animals and plants with high similarities with biomacromolecules in the human body. As an alkaline polysaccharide, chitosan (CS) attracts much attention in tissue regeneration and drug delivery with favorable biocompatibility, biodegradation, and antibacterial activity. However, to overcome its mechanical properties and degradation behavior drawbacks, a robust fibrous protein-silk fibroin (SF) was introduced to prepare the CS/SF composites. Not only can CS be combined with SF via the amide and hydrogen bond formation, but also their functions are complementary and tunable with the blending ratio. To further improve the performances of CS/SF composites, natural (e.g., hyaluronic acid and collagen) and synthetic biopolymers (e.g., polyvinyl alcohol and hexanone) were incorporated. Also, the CS/SF composites acted as slow-release carriers for inorganic non-metals (e.g., hydroxyapatite and graphene) and metal particles (e.g., silver and magnesium), which could enhance cell functions, facilitate tissue healing, and inhibit bacterial growth. This review presents the state-of-the-art and future perspectives of different biomaterials combined with CS/SF composites as sponges, hydrogels, membranes, particles, and coatings. Emphasis is devoted to the biological potentialities of these hybrid systems, which look rather promising toward a multitude of applications.
Collapse
Affiliation(s)
- Xiaojie Xing
- Key Laboratory of Oral Diseases & Fujian Provincial Engineering Research Center of Oral Biomaterial & Stomatological Key Lab of Fujian College and University, School and Hospital of Stomatology, Fujian Medical University, 88 Jiaotong Road, Fuzhou, Fujian 350004, China
| | - Yu Han
- Division of Craniofacial Development and Regeneration, Tohoku University Graduate School of Dentistry, 4-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan
| | - Hui Cheng
- Institute of Stomatology & Research Center of Dental Esthetics and Biomechanics, School and Hospital of Stomatology, Fujian Medical University, 246 Yangqiao Zhong Road, Fuzhou, Fujian 350002, China.
| |
Collapse
|
3
|
Li S, Cui Y, Liu H, Tian Y, Wang G, Fan Y, Wang J, Wu D, Wang Y. Application of bioactive metal ions in the treatment of bone defects. J Mater Chem B 2022; 10:9369-9388. [PMID: 36378123 DOI: 10.1039/d2tb01684b] [Citation(s) in RCA: 16] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
The treatment of bone defects is an important problem in clinical practice. The rapid development of bone tissue engineering (BTE) may provide a new method for bone defect treatment. Metal ions have been widely studied in BTE and demonstrated a significant effect in promoting bone tissue growth. Different metal ions can be used to treat bone defects according to specific conditions, including promoting osteogenic activity, inhibiting osteoclast activity, promoting vascular growth, and exerting certain antibacterial effects. Multiple studies have confirmed that metal ions-modified composite scaffolds can effectively promote bone defect healing. By studying current extensive research on metal ions in the treatment of bone defects, this paper reviews the mechanism of metal ions in promoting bone tissue growth, analyzes the loading mode of metal ions, and lists some specific applications of metal ions in different types of bone defects. Finally, this paper summarizes the advantages and disadvantages of metal ions and analyzes the future research trend of metal ions in BTE. This article can provide some new strategies and methods for future research and applications of metal ions in the treatment of bone defects.
Collapse
Affiliation(s)
- Shaorong Li
- Orthopaedic Medical Center, The Second Hospital of Jilin University, Changchun 130041, P. R. China.
| | - Yutao Cui
- Orthopaedic Medical Center, The Second Hospital of Jilin University, Changchun 130041, P. R. China.
| | - He Liu
- Orthopaedic Medical Center, The Second Hospital of Jilin University, Changchun 130041, P. R. China.
| | - Yuhang Tian
- Orthopaedic Medical Center, The Second Hospital of Jilin University, Changchun 130041, P. R. China.
| | - Gan Wang
- Orthopaedic Medical Center, The Second Hospital of Jilin University, Changchun 130041, P. R. China.
| | - Yi Fan
- Orthopaedic Medical Center, The Second Hospital of Jilin University, Changchun 130041, P. R. China.
| | - Jingwei Wang
- Orthopaedic Medical Center, The Second Hospital of Jilin University, Changchun 130041, P. R. China.
| | - Dankai Wu
- Orthopaedic Medical Center, The Second Hospital of Jilin University, Changchun 130041, P. R. China.
| | - Yanbing Wang
- Orthopaedic Medical Center, The Second Hospital of Jilin University, Changchun 130041, P. R. China.
| |
Collapse
|
4
|
The Effect of Strontium Ranelate on Fracture Healing: An Animal Study. BIOMED RESEARCH INTERNATIONAL 2020; 2020:1085324. [PMID: 33415138 PMCID: PMC7768587 DOI: 10.1155/2020/1085324] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/29/2020] [Revised: 08/05/2020] [Accepted: 11/11/2020] [Indexed: 01/15/2023]
Abstract
Background Strontium ranelate (StR) is an antiosteoporotic agent previously utilized for the enhancement of fracture union. We investigated the effects of StR on fracture healing using a rabbit model. Methods Forty adult female rabbits were included in the study and were divided in 2 equal groups, according to StR treatment or untreated controls. All animals were subjected to osteotomy of the ulna, while the contralateral ulna remained intact and served as a control for the biomechanical assessment of fracture healing. Animals in the study group received 600 mg/kg/day of StR orally. All animals received ordinary food. At 2 and 4 weeks, all animals were euthanatized and the osteotomy sites were evaluated for healing through radiological, biomechanical, and histopathological studies. Results The treatment group presented statistically significant higher callus diameter, total callus area, percentage of fibrous tissue (p < 0.001), vessels/mm2, number of total vessels, and lower osteoclast number/mm2 (p < 0.05) than the control group at 2 weeks. Additionally, the treatment group presented significantly higher percentages of new trabecular bone, vessels/mm2, osteoclast number/mm2, and lower values for callus diameter, as well as total callus area (p < 0.05), than the control group at 4 weeks. At 4 weeks, in the treatment group, force applied (p = 0.003), energy at failure (p = 0.004), and load at failure (p = 0.003) were all significantly higher in the forearm specimens with the osteotomized ulnae compared to those without. Radiological bone union was demonstrated for animals receiving StR at 4 weeks compared with controls (p = 0.045). Conclusion StR appears to enhance fracture healing but further studies are warranted in order to better elucidate the mechanisms and benefits of StR treatment.
Collapse
|
5
|
Miranda TS, Napimoga MH, De Franco L, Marins LM, Malta FDS, Pontes LA, Morelli FM, Duarte PM. Strontium ranelate improves alveolar bone healing in estrogen‐deficient rats. J Periodontol 2020; 91:1465-1474. [DOI: 10.1002/jper.19-0561] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2019] [Revised: 12/13/2019] [Accepted: 01/24/2020] [Indexed: 11/07/2022]
Affiliation(s)
| | - Marcelo Henrique Napimoga
- Faculdade São Leopoldo Mandic Instituto São Leopoldo Mandic Área de Imunologia Campinas São Paulo Brazil
| | - Leonardo De Franco
- Department of Periodontology Dental Research Division Guarulhos University Guarulhos São Paulo Brazil
| | - Letícia Macedo Marins
- Department of Periodontology Dental Research Division Guarulhos University Guarulhos São Paulo Brazil
| | - Fernando de Souza Malta
- Department of Periodontology Dental Research Division Guarulhos University Guarulhos São Paulo Brazil
| | - Louise Antonialice Pontes
- Department of Periodontology Dental Research Division Guarulhos University Guarulhos São Paulo Brazil
| | - Fernando Mendes Morelli
- Faculdade São Leopoldo Mandic Instituto São Leopoldo Mandic Área de Imunologia Campinas São Paulo Brazil
| | - Poliana Mendes Duarte
- Department of Periodontology Dental Research Division Guarulhos University Guarulhos São Paulo Brazil
- Department of Periodontology College of Dentistry University of Florida Gainesville FL
| |
Collapse
|
6
|
Marins LM, Napimoga MH, Malta FDS, Miranda TS, Nani EP, Franco BDST, da Silva HDP, Duarte PM. Effects of strontium ranelate on ligature-induced periodontitis in estrogen-deficient and estrogen-sufficient rats. J Periodontal Res 2019; 55:141-151. [PMID: 31539178 DOI: 10.1111/jre.12697] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2019] [Revised: 08/15/2019] [Accepted: 08/26/2019] [Indexed: 12/24/2022]
Abstract
BACKGROUND AND OBJECTIVES Strontium ranelate is a medication indicated for the treatment of osteoporosis that presents concomitant anti-resorptive and osteoanabolic dual biological activity. However, the effects of strontium ranelate on alveolar bone have been poorly explored. Furthermore, to date, there are no data on the effects of this medication on alveolar bone loss (BL) during conditions of estrogen deficiency. Therefore, the aim of this study was to evaluate the effects of strontium ranelate on ligature-induced periodontitis in estrogen-deficient and estrogen-sufficient rats. METHODS Ninety-six rats were assigned to one of the following groups: sham-surgery + water (estrogen-sufficient; n = 24); ovariectomy + water (estrogen-deficient; n = 24), sham-surgery + strontium ranelate (ranelate/estrogen-sufficient; n = 24) and; ovariectomy + strontium ranelate (ranelate/estrogen-deficient; n = 24). The rats received strontium ranelate or water from the 14th day after ovariectomy until the end of the experiment. On the 21st day after ovariectomy, one first mandibular molar received a ligature, while the contralateral tooth was left unligated. Eight rats per group were killed at 10, 20, and 30 days after ligature placement. Bone loss (BL) and trabecular bone area (TBA) were analyzed in the furcation area of ligated and unligated teeth at all experimental times by histometry. Tartrate-resistant acid phosphatase (TRAP) positive cells and immunohistochemical staining for osteocalcin (OCN), osteopontin (OPN), osteoprotegerin (OPG), and receptor activator of NF-КB ligand (RANKL) were assessed in the ligated teeth at 30 days after ligature placement. RESULTS At 10 and 30 days, ligated teeth of the estrogen-deficient group exhibited higher BL, when compared to all other groups (P < .05). At 10 days, TBAs were higher in the unligated teeth of strontium ranelate-treated groups, when compared to those of untreated groups (P < .05). At 30 days, the ligated teeth of the estrogen-deficient group exhibited lower TBA than the other groups (P < .05). There were no differences among groups regarding the number of TRAP-stained cells (P < .05). The strontium ranelate-treated groups exhibited lower expressions of OCN and RANKL than the untreated groups (P < .05). The estrogen-sufficient group presented higher staining for OPG than both treated and untreated estrogen-deficient groups (P < .05). CONCLUSIONS Strontium ranelate prevented ligature-induced BL in an estrogen-deficiency condition and, to a certain extent, increased TBA in the presence and absence of periodontal collapse in states of estrogen deficiency and estrogen sufficiency. Furthermore, strontium ranelate also affected the expression of bone markers, appearing to have acted predominantly as an anti-resorptive agent.
Collapse
Affiliation(s)
- Letícia Macedo Marins
- Dental Research Division, Department of Periodontology, Guarulhos University, Guarulhos, SP, Brazil
| | - Marcelo Henrique Napimoga
- Faculdade São Leopoldo Mandic, Instituto São Leopoldo Mandic, Área de Imunologia, Campinas, SP, Brazil
| | - Fernando de Souza Malta
- Dental Research Division, Department of Periodontology, Guarulhos University, Guarulhos, SP, Brazil
| | | | - Edson Parra Nani
- Faculdade São Leopoldo Mandic, Instituto São Leopoldo Mandic, Área de Imunologia, Campinas, SP, Brazil
| | | | | | - Poliana Mendes Duarte
- Dental Research Division, Department of Periodontology, Guarulhos University, Guarulhos, SP, Brazil.,Department of Periodontology, College of Dentistry, University of Florida, Gainesville, FL, USA
| |
Collapse
|
7
|
Cao GL, Tian FM, Liu GY, Song HP, Yuan LL, Geng LD, Bei MJ, Zheng ZY, Zhang L. Strontium Ranelate Combined with Insulin Is as Beneficial as Insulin Alone in Treatment of Fracture Healing in Ovariectomized Diabetic Rats. Med Sci Monit 2018; 24:6525-6536. [PMID: 30221634 PMCID: PMC6154119 DOI: 10.12659/msm.911573] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
Background Type 2 diabetes mellitus (T2DM) and estrogen deficiency both predispose fracture patients to increased risk of delayed union or nonunion. The present study investigated the effects of strontium ranelate (SR) on fracture healing in ovariectomized (OVX) diabetic rats. Material/Methods A mid-shaft fracture was established in female normal control (CF), diabetic (DF), and OVX diabetic (DOF) rats. Treated DOF rats received either insulin alone (DOFI) or combined with SR (DOFIS). All rats were euthanized at 2 or 3 weeks after fracture. Fracture healing was evaluated using radiological, histological, immunohistochemical, and micro-computed tomography analyses. Results At 3 weeks after fracture, radiological and histological evaluations demonstrated delayed fracture healing in the DF group compared with the CF group, which was exacerbated by OVX, as indicated by the significantly lower X-ray score, BMD, BV/TV, and Md.Ar/Ps.Cl.Ar, and the markedly decreased OCN and Col I expression in the DOF group. All these changes were prevented by insulin alone or combined with SR treatment. In comparison with the DOFI group, DOFIS rats displayed markedly higher OCN expression at 2 weeks after fracture and Col I expression at 2 and 3 weeks after fracture. Conclusions These results demonstrated delayed fracture healing with preexisting estrogen deficiency and T2DM. While insulin alone and combined with SR were both effective in promoting bone fracture healing in this model, their combined treatment showed significant improvement in promoting osteogenic marker expression, but not of the radiological appearance, compared with insulin alone.
Collapse
Affiliation(s)
- Guo-Long Cao
- Department of Orthopedic Surgery, Hebei Medical University, Shijiazhuang, Hebei, China (mainland)
| | - Fa-Ming Tian
- Medical Research Center, North China University of Science and Technology, Tangshan, Hebei, China (mainland).,International Science and Technology Cooperation Base of Geriatric Medicine, Department of International Cooperation, Ministry of Science and Technology of China, Tangshan, Hebei, China (mainland)
| | - Guang-Yuan Liu
- Department of Orthopedic Surgery, Hebei Medical University, Shijiazhuang, Hebei, China (mainland)
| | - Hui-Ping Song
- Department of Orthopedic Surgery, The Affiliated Hospital of North China University of Science and Technology, Tangshan, Hebei, China (mainland)
| | - Lei-Liang Yuan
- Department of Orthopedic Surgery, The Affiliated Hospital of North China University of Science and Technology, Tangshan, Hebei, China (mainland)
| | - Lin-Dan Geng
- Department of Orthopedic Surgery, The Affiliated Hospital of North China University of Science and Technology, Tangshan, Hebei, China (mainland)
| | - Ming-Jian Bei
- Department of Orthopedic Surgery, The Affiliated Hospital of North China University of Science and Technology, Tangshan, Hebei, China (mainland)
| | - Zhi-Yuan Zheng
- Department of Orthopedic Surgery, The Affiliated Hospital of North China University of Science and Technology, Tangshan, Hebei, China (mainland)
| | - Liu Zhang
- Department of Orthopedic Surgery, Hebei Medical University, Shijiazhuang, Hebei, China (mainland).,Mine Medical Security Center, Meitan General Hospital, Beijing, China (mainland)
| |
Collapse
|
8
|
Strontium ranelate promotes odonto-/osteogenic differentiation/mineralization of dental papillae cells in vitro and mineralized tissue formation of the dental pulp in vivo. Sci Rep 2018; 8:9224. [PMID: 29907831 PMCID: PMC6003917 DOI: 10.1038/s41598-018-27461-7] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2017] [Accepted: 06/04/2018] [Indexed: 12/28/2022] Open
Abstract
This study examined the effects and mechanisms of strontium ranelate (SrRn)-a drug used to treat osteoporosis-on the proliferation and differentiation/mineralization of cloned dental pulp-like cells (mouse dental papillae cells; MDPs). It also determined whether topical application of SrRn to exposed dental pulp tissue promotes the formation of mineralized tissue in vivo. The MDPs were cultured with or without SrRn, and cell proliferation, odonto-/osteoblastic gene expression, mineralized nodule formation, and Akt phosphorylation were evaluated. The formation of mineralized tissue in SrRn-treated pulp tissue in rat upper first molars was evaluated histologically. The SrRn up-regulated cell proliferation and expression of Alp (alkaline phosphatase), Bsp (bone sialoprotein), Dmp (dentin matrix acidic phosphoprotein)-1, Dspp (dentin sialophosphoprotein), and Oc (osteocalcin) in a dose-dependent manner. Mineralized nodule formation was also enhanced by SrRn. NPS-2143, a calcium-sensing receptor (CaSR) antagonist, and siRNA against the CaSR gene blocked SrRn-induced proliferation, odonto-/osteoblastic gene expression, and mineralized nodule formation. SrRn induced Akt phosphorylation, and this was blocked by NPS-2143. Topical application of SrRn to exposed rat molar pulps induced the formation of osteodentin-like mineralized tissue. Our study revealed for the first time that SrRn promotes proliferation and odonto-/osteogenic differentiation/mineralization of MDPs via PI3K/Akt signaling activated by CaSR in vitro; mineralized tissue forms from the dental pulp in vivo.
Collapse
|
9
|
Masalskas BF, Martins Júnior W, Leoni GB, Faloni APDS, Marcaccini AM, Silva Sousa YTC, Castro-Raucci LMSD. Local delivery of strontium ranelate promotes regeneration of critical size bone defects filled with collagen sponge. J Biomed Mater Res A 2017; 106:333-341. [PMID: 28913909 DOI: 10.1002/jbm.a.36237] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2017] [Revised: 08/31/2017] [Accepted: 09/12/2017] [Indexed: 01/12/2023]
Abstract
The effect of local delivery of strontium ranelate (SR) on bone regeneration of critical size bone defects filled with collagen sponge was evaluated. Bone defects of 5 mm diameter created in rat calvaria were filled with collagen sponge (C); collagen sponge with 5 mM Sr2+ SR (C5SR) or collagen sponge with 50 mM Sr2+ SR (C50SR). After 2, 4, and 6 weeks, bone volume (BV), bone surface (BS), trabecular thickness (Tb.Th), trabecular number (Tb.N), and trabecular separation (Tb.Sp) were evaluated by computed microtomography. At 6 weeks, histological analysis was performed. Intragroup comparisons were made by the Friedman test, while comparisons between groups were made by Kruskal-Wallis test (α = 5%). All groups showed increased BV, BS, Tb.Th, and Tb.N over time, but only C50SR promoted the reduction of Tb.Sp (p < 0.05). No significant differences between groups were detected at weeks 2 and 4. However, C50SR showed the highest values of BV, BS, and Tb.Th at 6 weeks (p < 0.05). Histological analysis revealed connective tissue in C and C5SR and immature bone tissue in C50SR. Local delivery of SR 50 mM Sr2+ associated with collagen sponge increased and accelerated bone regeneration in critical bone defects. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A: 333-341, 2018.
Collapse
Affiliation(s)
| | - Walter Martins Júnior
- School of Dentistry, University of Ribeirao Preto, Ribeirao Preto, Sao Paulo, Brazil
| | | | | | | | | | | |
Collapse
|
10
|
Ehret C, Aid-Launais R, Sagardoy T, Siadous R, Bareille R, Rey S, Pechev S, Etienne L, Kalisky J, de Mones E, Letourneur D, Amedee Vilamitjana J. Strontium-doped hydroxyapatite polysaccharide materials effect on ectopic bone formation. PLoS One 2017; 12:e0184663. [PMID: 28910401 PMCID: PMC5598993 DOI: 10.1371/journal.pone.0184663] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2017] [Accepted: 08/28/2017] [Indexed: 11/29/2022] Open
Abstract
Previous studies performed using polysaccharide-based matrices supplemented with hydroxyapatite (HA) particles showed their ability to form in subcutaneous and intramuscular sites a mineralized and osteoid tissue. Our objectives are to optimize the HA content in the matrix and to test the combination of HA with strontium (Sr-HA) to increase the matrix bioactivity. First, non-doped Sr-HA powders were combined to the matrix at three different ratios and were implanted subcutaneously for 2 and 4 weeks. Interestingly, matrices showed radiolucent properties before implantation. Quantitative analysis of micro-CT data evidenced a significant increase of mineralized tissue formed ectopically with time of implantation and allowed us to select the best ratio of HA to polysaccharides of 30% (w/w). Then, two Sr-substitution of 8% and 50% were incorporated in the HA powders (8Sr-HA and 50Sr-HA). Both Sr-HA were chemically characterized and dispersed in matrices. In vitro studies performed with human mesenchymal stem cells (MSCs) demonstrated the absence of cytotoxicity of the Sr-doped matrices whatever the amount of incorporated Sr. They also supported osteoblastic differentiation and activated the expression of one late osteoblastic marker involved in the mineralization process i.e. osteopontin. In vivo, subcutaneous implantation of these Sr-doped matrices induced osteoid tissue and blood vessels formation.
Collapse
Affiliation(s)
- C. Ehret
- Inserm U1026, University of Bordeaux, Tissue Bioengineering, U1026, Bordeaux, France
| | - R. Aid-Launais
- Inserm U1148, LVTS, X. Bichat Hospital, University Paris Diderot F-75018 Paris, Institut Galilée, University Paris 13, Villetaneuse, France
| | - T. Sagardoy
- Inserm U1026, University of Bordeaux, Tissue Bioengineering, U1026, Bordeaux, France
| | - R. Siadous
- Inserm U1026, University of Bordeaux, Tissue Bioengineering, U1026, Bordeaux, France
| | - R. Bareille
- Inserm U1026, University of Bordeaux, Tissue Bioengineering, U1026, Bordeaux, France
| | - S. Rey
- Inserm U1026, University of Bordeaux, Tissue Bioengineering, U1026, Bordeaux, France
| | - S. Pechev
- ICMCB, Bordeaux University, Bordeaux, France
| | - L. Etienne
- ICMCB, Bordeaux University, Bordeaux, France
| | - J. Kalisky
- Inserm U1026, University of Bordeaux, Tissue Bioengineering, U1026, Bordeaux, France
| | - E. de Mones
- Inserm U1026, University of Bordeaux, Tissue Bioengineering, U1026, Bordeaux, France
- CHU Bordeaux, Oral and Maxillo-Facial Department, Bordeaux, France
| | - D. Letourneur
- Inserm U1148, LVTS, X. Bichat Hospital, University Paris Diderot F-75018 Paris, Institut Galilée, University Paris 13, Villetaneuse, France
| | - J. Amedee Vilamitjana
- Inserm U1026, University of Bordeaux, Tissue Bioengineering, U1026, Bordeaux, France
- * E-mail:
| |
Collapse
|